Adulthood leukodystrophies.
Köhler W, Curiel J, Vanderver A.
Nat Rev Neurol. 2018 Feb;14(2):94-105. doi: 10.1038/nrneurol.2017.175. Epub 2018 Jan 5.
Myelination of the nervous system: mechanisms and functions.
Nave KA, Werner HB.
Annu Rev Cell Dev Biol. 2014;30:503-33. doi: 10.1146/annurev-cellbio-100913-013101.
Case definition and classification of leukodystrophies and leukoencephalopathies.
Vanderver A, Prust M, Tonduti D, Mochel F, Hussey HM, Helman G, Garbern J, Eichler F, Labauge P, Aubourg P, Rodriguez D, Patterson MC, Van Hove JL, Schmidt J, Wolf NI, Boespflug-Tanguy O, Schiffmann R, van der Knaap MS; GLIA Consortium.
Mol Genet Metab. 2015 Apr;114(4):494-500. doi: 10.1016/j.ymgme.2015.01.006. Epub 2015 Jan 29.
An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.
Ashrafi MR, Amanat M, Garshasbi M, Kameli R, Nilipour Y, Heidari M, Rezaei Z, Tavasoli AR.
Expert Rev Neurother. 2020 Jan;20(1):65-84. doi: 10.1080/14737175.2020.1699060. Epub 2019 Dec 12.
MRI signs of CNS demyelinating diseases.
Etemadifar M, Ashourizadeh H, Nouri H, Kargaran PK, Salari M, Rayani M, Aghababaee A, Abhari AP.
Mult Scler Relat Disord. 2021 Jan;47:102665. doi: 10.1016/j.msard.2020.102665. Epub 2020 Dec 4.
[Genetic demyelinating diseases].
Labauge P, Boespflug-Tanguy O.
Presse Med. 2010 Mar;39(3):363-70. doi: 10.1016/j.lpm.2009.11.011. Epub 2010 Feb 18.
Leukodystrophies.
Perlman SJ, Mar S.
Adv Exp Med Biol. 2012;724:154-71. doi: 10.1007/978-1-4614-0653-2_13.
Demyelinating diseases.
Love S.
J Clin Pathol. 2006 Nov;59(11):1151-9. doi: 10.1136/jcp.2005.031195.
Pathology of demyelinating diseases.
Popescu BF, Lucchinetti CF.
Annu Rev Pathol. 2012;7:185-217. doi: 10.1146/annurev-pathol-011811-132443.
White matter disease derived from vascular and demyelinating origins.
Zhang LJ, Tian DC, Yang L, Shi K, Liu Y, Wang Y, Shi FD.
Stroke Vasc Neurol. 2024 Aug 27;9(4):344-350. doi: 10.1136/svn-2023-002791.
